Expression of Estrogen Receptors (ER), Progesterone Receptors (PR) and HER-2/neu receptors in Endometrial Carcinoma and their associations with histological types, grades and stages of the tumor

被引:11
|
作者
Waqar, Samina [3 ]
Khan, Saleem Ahmad [1 ]
Sarfraz, Tariq [3 ]
Waqar, Saba [2 ]
机构
[1] Mil Hosp, Army Med Coll, Dept Hematol, Rawalpindi, Pakistan
[2] Mil Hosp, Army Med Coll, Dept Dent Mat, Rawalpindi, Pakistan
[3] Mil Hosp, Army Med Coll, Dept Histopathol, Rawalpindi, Pakistan
关键词
Endometrial Carcinoma; Estrogen Receptors; Her-2/Neu; Progesterone Receptors; UTERINE SEROUS CARCINOMA; AGGRESSIVE VARIANT; TARGETED THERAPY; CANCER; OVEREXPRESSION; ADENOCARCINOMA; AMPLIFICATION; HER2/NEU;
D O I
10.12669/pjms.342.13637
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To study and detect immunohistochemical expression of Estrogen Receptors, Progestrone Receptors and HER-2/neu Receptors in Endometrial Carcinoma (EC) and to find their associations with histological types, grades and stages of the tumor. Methods: A cross sectional study of one year duration from January 2016 to January 2017 was conducted at Histopathology department of Army Medical College, Rawalpindi. A non-probability purposive sampling technique was used to include 56 cases of EC. The specimens were tested for ER, PR and HER-2/neu expression using immunohistochemical analysis. Data was analyzed in SPSS and the significance of association of expression of the receptors with histological types, grades and stages of the tumor was assessed. Results: Significant association of Her-2/neu overexpression with histological types and grades of EC was seen, whereas the association of ER and PR expression with histological types, grades and stage of EC was statistically insignificant. Conclusion: It is suggested that EC showing over expression of HER2/neu with immunohistochemistry may be treated with anti HER-2/neu treatment with better chances of survival and decreased post-treatment morbidity.
引用
收藏
页码:266 / 271
页数:6
相关论文
共 38 条
  • [1] Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications
    Ciocca, Daniel R.
    Gago, Francisco E.
    Fanelli, Mariel A.
    Calderwood, Stuart K.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2006, 102 (1-5) : 32 - 40
  • [2] A reliable method of demonstrating HER-2/neu, estrogen receptors, and progesterone receptors on routinely processed cytologic material
    McKee, GT
    Tambouret, RH
    Finkelstein, D
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2001, 9 (04): : 352 - 357
  • [3] Immunohistochemical Expression of ER, PR and HER2/neu in Endometrial Carcinoma
    Mohapatra, Kaustav
    Shivalingaiah, Sheela Devi C.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 17 (03)
  • [4] Prevalence of androgen receptors in invasive breast carcinoma and its relation with estrogen receptor, progesterone receptor and Her2/neu expression
    Alshenawy, Hanan AlSaeid
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2012, 24 (02) : 77 - 83
  • [5] Evaluation of Estrogen and Progesterone Receptors and Her-2 Expression with Grading in the Fine-needle Aspirates of Patients with Breast Carcinoma
    Toi, Pampa Ch
    Neelaiah, Siddaraju
    Dharanipragada, Kadambari
    Surendra, Kumar
    JOURNAL OF CYTOLOGY, 2018, 35 (04) : 223 - 228
  • [6] Expression of ER, PR, and Her-2/neu in Endometrial Cancer: A Clinicopathological Study
    Srijaipracharoen, Sunamchok
    Tangjitgamol, Siriwan
    Tanvanich, Sujitra
    Manusirivithaya, Sumonmal
    Khunnarong, Jakkapan
    Thavaramara, Thaovalai
    Leelahakorn, Surawute
    Pataradool, Kamol
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (01) : 215 - 220
  • [7] Expression of ER, PR, and HER-2 Neu and correlation with tumor markers in gall bladder carcinoma
    Mani, Rishit
    Gupta, Amit
    Gupta, Sweety
    Goyal, Bela
    Mishra, Rahul
    Tandon, Amoli
    Sharma, Oshin
    Rohilla, Kusum K.
    Kishore, Sanjeev
    Dhar, Puneet
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (05) : 1279 - 1287
  • [8] Expression of estrogen receptor, progesterone receptor, and Her-2/neu in primary and extra-corporeal endometrial cancer
    Tangjitgamol, Siriwan
    Tanvanich, Sujitra
    Srijaipracharoen, Sunamchok
    Manusirivithaya, Sumonmal
    HISTOLOGY AND HISTOPATHOLOGY, 2013, 28 (06) : 787 - 794
  • [9] Immunohistochemical Expression of ER, PR and HER2/neu in Endometrial Carcinoma
    Kaustav Mohapatra
    Sheela devi C. Shivalingaiah
    Indian Journal of Gynecologic Oncology, 2019, 17
  • [10] Association of hTERT expression, Her2Neu, estrogen receptors, progesterone receptors, with telomere length before and at the end of treatment in breast cancer patients
    Murillo-Ortiz, Blanca Olivia
    Garcia-Corrales, Kenia
    Martinez-Garza, Sandra
    Romero-Vazquez, Marcos Javier
    Agustin-Godinez, Eduardo
    Escareno-Gomez, Andrea
    Silva-Guerrero, Daniela Guadalupe
    Mendoza-Ramirez, Saulo
    Murguia-Perez, Mario
    FRONTIERS IN MEDICINE, 2024, 11